Free Trial

Punch & Associates Investment Management Inc. Raises Holdings in Addus HomeCare Corporation $ADUS

Addus HomeCare logo with Medical background

Key Points

  • Punch & Associates Investment Management Inc. raised its holdings in Addus HomeCare Corporation by 2.1%, owning 110,286 shares worth approximately $10.91 million.
  • Significant institutional interest in Addus HomeCare is evident, with over 95% of the stock held by hedge funds and other institutional investors, indicating strong market confidence.
  • Analysts have reported a positive outlook for Addus HomeCare, with several firms issuing buy ratings and targeting prices up to $145.00 for the stock.
  • MarketBeat previews the top five stocks to own by October 1st.

Punch & Associates Investment Management Inc. lifted its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 2.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 110,286 shares of the company's stock after buying an additional 2,260 shares during the period. Punch & Associates Investment Management Inc. owned about 0.60% of Addus HomeCare worth $10,906,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Petrus Trust Company LTA raised its stake in shares of Addus HomeCare by 494.6% during the 1st quarter. Petrus Trust Company LTA now owns 10,096 shares of the company's stock worth $998,000 after buying an additional 8,398 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock worth $1,026,000 after buying an additional 459 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Addus HomeCare by 8.2% during the 1st quarter. Integrated Wealth Concepts LLC now owns 7,844 shares of the company's stock worth $776,000 after buying an additional 596 shares in the last quarter. EP Wealth Advisors LLC raised its stake in shares of Addus HomeCare by 24.1% during the 1st quarter. EP Wealth Advisors LLC now owns 2,732 shares of the company's stock worth $270,000 after buying an additional 530 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock worth $682,000 after buying an additional 1,347 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, Director Veronica Hill-Milbourne sold 1,571 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director owned 5,067 shares in the company, valued at approximately $582,350.31. This represents a 23.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the transaction, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,310 shares of company stock worth $3,958,375. 4.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. UBS Group assumed coverage on Addus HomeCare in a research note on Tuesday. They set a "buy" rating and a $145.00 target price for the company. Macquarie restated an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. TD Cowen upped their price target on Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, Stephens restated an "overweight" rating and issued a $140.00 price target on shares of Addus HomeCare in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $138.89.

View Our Latest Analysis on Addus HomeCare

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $113.22 on Friday. The business's fifty day moving average price is $112.01 and its two-hundred day moving average price is $107.00. The stock has a market cap of $2.09 billion, a PE ratio of 24.99, a price-to-earnings-growth ratio of 1.71 and a beta of 0.85. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The firm had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare's quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.35 EPS. On average, analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.